2024년에 44억 달러로 추정되는 바이오프로세스 백 세계 시장은 2024-2030년간 CAGR 17.8%로 성장하여 2030년에는 116억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 2D 바이오프로세스 백은 CAGR 20.0%를 나타내고, 분석 기간 종료시에는 66억 달러에 이를 것으로 예측됩니다. 3D 바이오프로세스 백 분야의 성장률은 분석 기간 CAGR로 16.4%로 추정됩니다.
미국 시장은 11억 달러, 중국은 CAGR 16.7%를 보일 것으로 예측
미국의 바이오프로세스 백 시장은 2024년에 11억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 18억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 16.7%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 16.7%와 15.1%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.8%를 보일 전망입니다.
세계의 바이오프로세스 백 시장 - 주요 동향과 촉진요인 정리
바이오프로세스 백이 바이오 의약품 및 생명공학 분야에 혁명을 일으킬 이유는 무엇인가?
바이오프로세스 백은 현대 바이오 의약품 제조의 핵심으로, 의약품 제조의 무균성, 효율성, 확장성을 보장하는 데 중요한 역할을 합니다. 특수 고분자 필름으로 제작된 일회용 바이오프로세싱 백은 세포 배양, 발효, 배지 보존, 생물학적 제품 운송을 위한 봉쇄 솔루션으로 사용됩니다. 단일클론항체, 백신, 유전자치료, 맞춤의료 등 생물학적 제제의 급속한 확대에 따라 고성능 바이오프로세스 백 수요가 급증하고 있습니다. 바이오 제약 기업들은 오염 위험을 제거하고, 운영 비용을 절감하며, 생산 유연성을 높이기 위해 이러한 일회용 솔루션을 점점 더 많이 채택하고 있습니다.
기존의 스테인리스 스틸 바이오리액터에서 일회용 시스템으로 전환하면서 바이오프로세스 백의 성장이 더욱 가속화되고 있습니다. 일회용 바이오프로세스 백은 대규모 세척 및 검증이 필요한 재사용 시스템과 달리 운영을 간소화하고, 다운타임을 최소화하며, 다품종 생산 시설에서 신속한 전환을 지원합니다. 코로나19 백신에 대한 수요 증가와 세포 및 유전자 치료제 제조의 발전도 연구기관, 위탁생산기관(CMO), 생명공학 기업에서 바이오프로세스 백의 채택을 가속화하고 있습니다. 바이오프로세스가 계속 발전함에 따라 바이오프로세스 백은 생물학적 제제 제조의 효율성, 무균성, 비용 효율성을 최적화하는 데 중요한 역할을 할 것입니다.
기술 혁신은 어떻게 바이오프로세스 백의 성능을 향상시키고 있는가?
재료 과학, 장벽 보호 및 바이오프로세스 기술의 획기적인 발전으로 바이오프로세스 백의 성능은 크게 변화하여 제약 응용 분야에서보다 안정적이고 효율적인 성능을 발휘하고 있습니다. 이 분야에서 가장 주목할 만한 혁신 중 하나는 내구성, 내화학성, 가스 투과성 제어를 강화하는 다층 폴리머 필름의 개발입니다. 폴리에틸렌, 에틸렌비닐알코올(EVOH), 폴리염화비닐(PVC)로 만들어지는 이 고성능 필름은 용출물, 추출물, 미생물 오염에 대한 탁월한 보호 기능을 제공합니다. 또한, 감마선에 안정적인 소재를 사용하여 멸균 처리 후에도 바이오프로세스 백의 무결성이 유지되어 중요한 의약품 제조 공정에서 사용성이 향상되었습니다.
바이오프로세스 백 기술의 또 다른 큰 돌파구는 실시간 모니터링과 자동화의 통합입니다. 센서가 내장된 스마트 바이오프로세스 백은 pH, 온도, 용존 산소, 압력 레벨을 추적할 수 있으며, 공정 최적화를 위한 실시간 데이터를 제공합니다. 이러한 발전은 품질 관리를 강화하고 바이오 의약품 제조에서 배치 불량 위험을 줄일 수 있습니다. 또한, 무균 퀵 커넥트 시스템, 무균 용접 기술 등 바이오프로세스용 백 커넥터의 기술 혁신은 무균성을 유지하면서 유체 이송 효율을 향상시키고 있습니다. 세포 치료 및 유전자 치료 용도 등 특정 생물학적 제제에 맞는 맞춤형 바이오프로세스 백의 개발이 진행되고 있으며, 최신 바이오프로세스 환경에서 이러한 솔루션의 범용성이 더욱 확대되고 있습니다.
바이오프로세스 백의 성장을 가속하는 시장 동향은 무엇인가?
세계 바이오프로세스 백 시장은 바이오 의약품 제조에 일회용 기술 채택이 증가함에 따라 크게 성장하고 있습니다. 업계를 형성하는 가장 영향력 있는 트렌드 중 하나는 유연하고 모듈화된 바이오프로세스 설비로의 전환입니다. 바이오 제약 기업이 더 높은 민첩성과 효율성을 추구함에 따라, 일회용은 모듈식 클린룸 설계 및 하이브리드 제조 시스템에 통합되어 스테인리스 스틸 장비에 대한 설비 투자를 줄이고 있습니다. 개발-제조수탁기관(CDMO)에 대한 의존도가 높아지고 있는 것도 시장 확대에 기여하고 있습니다. CDMO는 확장 가능하고 비용 효율적인 일회용 바이오프로세싱 솔루션을 우선순위에 두고 있기 때문입니다.
바이오프로세스 백 수요를 견인하는 또 다른 중요한 트렌드는 개인 맞춤형 의료, 재생 의료, 세포 기반 면역 요법을 포함한 첨단 치료의 부상입니다. 이러한 고부가가치 생물학적 제제의 경우 무균 및 무공해 환경이 가장 중요하며, 일회용 바이오프로세스 백이 보관 및 운송을 위해 선택됩니다. 또한, 특히 mRNA 백신과 바이러스 벡터 백신을 중심으로 백신 제조가 확대됨에 따라 신속한 생산 스케일링이 가능한 일회용 바이오프로세스 솔루션에 대한 수요가 증가하고 있습니다. 또한, 친환경 바이오프로세스를 지향하는 움직임도 활발해지면서 플라스틱 폐기물을 줄이고 의약품 제조의 지속가능성을 높이기 위해 재활용 가능하고 생분해 가능한 바이오프로세스 백의 소재가 검토되고 있습니다.
바이오프로세스 백 시장 전망를 형성하는 주요 성장 촉진요인은 무엇인가?
바이오프로세스 백 시장의 성장은 바이오 의약품 수요 증가, 일회용 기술 발전, 의약품 제조의 무균성 향상 필요성 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 가장 중요한 성장 요인 중 하나는 단클론 항체, 재조합 단백질, 세포치료제 등 생물학적 제제 파이프라인의 확대입니다. 제약회사들이 세계 헬스케어 수요에 대응하기 위해 생산을 확대하는 가운데, 바이오프로세스 백의 확장성과 무균성의 장점은 최신 바이오 제조에 필수적인 요소로 자리 잡고 있습니다.
시장을 형성하는 또 다른 중요한 촉진요인은 일회용 시스템이 제공하는 비용 효율성과 운영의 유연성입니다. 기존의 스테인리스 스틸 바이오리액터에 비해 바이오프로세스 백은 대규모 세척이 필요 없고, 교차 오염의 위험을 줄이며, 제조 시설의 처리 시간을 단축할 수 있습니다. 바이오프로세스에서 자동화 및 디지털화의 역할이 증가함에 따라 스마트 바이오프로세스 백은 실시간 데이터 모니터링 및 공정 최적화를 제공함으로써 시장 성장을 가속하고 있습니다. 또한, 일회용 바이오프로세싱 기술에 대한 규제 당국의 지원은 특히 바이오의약품 인프라가 빠르게 발전하고 있는 신흥국 시장에서 일회용 바이오프로세싱 기술의 폭넓은 채택을 촉진하고 있습니다.
재료 과학, 바이오프로세스 자동화, 지속 가능한 패키징의 진보가 업계를 재편하는 가운데 고성능 바이오프로세스 백에 대한 수요는 가속화될 것으로 예측됩니다. 무균성을 높이고, 공정 효율을 개선하고, 유연한 제조를 지원하는 바이오프로세스 백은 전 세계 바이오 의약품 제조의 혁신과 효율을 촉진하고 바이오 의약품 및 생명공학 부문의 중요한 구성 요소로 남을 것입니다.
부문
제품 유형(2D 바이오프로세스 백, 3D 바이오프로세스 백, 기타 백 및 액세서리);워크플로우 프로세스 유형(Upstream 프로세스, Downstream 프로세스, 프로세스 개발);최종사용자(제약회사 및 바이오 제약회사 최종사용자, CMO 및 CRO 최종사용자, 학술연구기관 최종사용자)
조사 대상 기업 예
Avantor, Inc.
CellBios Healthcare & Lifesciences Pvt. Ltd.
Corning, Inc.
Dow, Inc.
Entegris, Inc.
Kiefel GmbH
Meissner Filtration Products, Inc.
PROAnalytics, LLC
Saint-Gobain Life Sciences
Sartorius AG
Single Use Support GmbH
Thermo Fisher Scientific, Inc.
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁합니다.
Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
LSH
영문 목차
영문목차
Global Bioprocess Bags Market to Reach US$11.6 Billion by 2030
The global market for Bioprocess Bags estimated at US$4.4 Billion in the year 2024, is expected to reach US$11.6 Billion by 2030, growing at a CAGR of 17.8% over the analysis period 2024-2030. 2D Bioprocess Bags, one of the segments analyzed in the report, is expected to record a 20.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth in the 3D Bioprocess Bags segment is estimated at 16.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 16.7% CAGR
The Bioprocess Bags market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 16.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.7% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.
Global Bioprocess Bags Market - Key Trends & Drivers Summarized
Why Are Bioprocess Bags Revolutionizing the Biopharmaceutical and Biotechnology Sectors?
Bioprocess bags have become a cornerstone of modern biopharmaceutical manufacturing, playing a crucial role in ensuring sterility, efficiency, and scalability in drug production. These single-use bioprocessing bags, made from specialized polymer films, serve as containment solutions for cell culture, fermentation, media storage, and transportation of biological products. With the rapid expansion of biologics, including monoclonal antibodies, vaccines, gene therapies, and personalized medicine, the demand for high-performance bioprocess bags has surged. Biopharmaceutical companies are increasingly adopting these single-use solutions to eliminate contamination risks, reduce operational costs, and enhance flexibility in production.
The shift from traditional stainless-steel bioreactors to single-use systems has further propelled the growth of bioprocess bags. Unlike reusable systems that require extensive cleaning and validation, single-use bioprocess bags streamline operations, minimize downtime, and support faster changeovers in multi-product facilities. The rising demand for COVID-19 vaccines, along with advancements in cell and gene therapy manufacturing, has also accelerated the adoption of bioprocess bags across research institutions, contract manufacturing organizations (CMOs), and biotech firms. As bioprocessing continues to evolve, bioprocess bags are poised to play a crucial role in optimizing efficiency, sterility, and cost-effectiveness in biologics production.
How Are Technological Innovations Enhancing the Performance of Bioprocess Bags?
Significant advancements in material science, barrier protection, and bioprocessing technology have transformed the capabilities of bioprocess bags, making them more reliable and efficient for pharmaceutical applications. One of the most notable innovations in this space is the development of multi-layered polymer films that enhance durability, chemical resistance, and gas permeability control. These high-performance films, often made from polyethylene, ethylene vinyl alcohol (EVOH), and polyvinyl chloride (PVC), provide superior protection against leachables, extractables, and microbial contamination. Additionally, the incorporation of gamma-stable materials ensures that bioprocess bags maintain integrity even after sterilization processes, improving their usability in critical drug manufacturing steps.
Another major breakthrough in bioprocess bag technology is the integration of real-time monitoring and automation. Smart bioprocess bags equipped with embedded sensors can track pH, temperature, dissolved oxygen, and pressure levels, providing real-time data for process optimization. This advancement enhances quality control and reduces the risk of batch failures in biopharmaceutical production. Furthermore, innovations in bioprocess bag connectors, such as aseptic quick-connect systems and sterile welding technologies, are improving fluid transfer efficiency while maintaining sterility. The ongoing development of customized bioprocess bags tailored for specific biologics, including cell and gene therapy applications, is further expanding the versatility of these solutions in modern bioprocessing environments.
Which Market Trends Are Driving the Growth of Bioprocess Bags?
The global bioprocess bags market is experiencing significant growth, driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing. One of the most impactful trends shaping the industry is the shift toward flexible and modular bioprocessing facilities. As biopharma companies strive for greater agility and efficiency, single-use bioprocess bags are being integrated into modular cleanroom designs and hybrid manufacturing systems, reducing capital investments in stainless-steel equipment. The growing reliance on contract development and manufacturing organizations (CDMOs) has also contributed to market expansion, as these organizations prioritize scalable and cost-effective single-use bioprocessing solutions.
Another key trend driving demand for bioprocess bags is the rise of advanced therapies, including personalized medicine, regenerative medicine, and cell-based immunotherapies. The need for sterile, contamination-free environments is paramount in these high-value biologics, making single-use bioprocess bags a preferred choice for storage and transport. Additionally, the expansion of vaccine manufacturing, particularly mRNA and viral vector vaccines, has increased the demand for single-use bioprocess solutions that facilitate rapid production scaling. The push toward environmentally friendly bioprocessing is also gaining traction, with companies exploring recyclable and biodegradable bioprocess bag materials to reduce plastic waste and enhance sustainability in pharmaceutical manufacturing.
What Are the Key Growth Drivers Shaping the Future of the Bioprocess Bags Market?
The growth in the bioprocess bags market is driven by several critical factors, including the increasing demand for biopharmaceuticals, advancements in single-use technologies, and the need for improved sterility in drug manufacturing. One of the most significant growth drivers is the expanding pipeline of biologic drugs, including monoclonal antibodies, recombinant proteins, and cell therapies. As pharmaceutical companies ramp up production to meet global healthcare demands, the scalability and sterility advantages of bioprocess bags make them an essential component of modern biomanufacturing.
Another key driver shaping the market is the cost-efficiency and operational flexibility offered by single-use systems. Compared to traditional stainless-steel bioreactors, bioprocess bags eliminate the need for extensive cleaning, reduce cross-contamination risks, and enable faster turnaround times in manufacturing facilities. The growing role of automation and digitalization in bioprocessing is also fueling market growth, with smart bioprocess bags offering real-time data monitoring and process optimization. Additionally, regulatory support for single-use bioprocessing technologies is encouraging broader adoption, particularly in emerging markets where biopharmaceutical infrastructure is rapidly developing.
As advancements in material science, bioprocessing automation, and sustainable packaging continue to reshape the industry, the demand for high-performance bioprocess bags is expected to accelerate. With their ability to enhance sterility, improve process efficiency, and support flexible manufacturing, bioprocess bags are set to remain a vital component of the biopharmaceutical and biotechnology sectors, driving innovation and efficiency in global biologics production.
SCOPE OF STUDY:
The report analyzes the Bioprocess Bags market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags and Accessories); Workflow Process Type (Upstream Process, Downstream Process, Process Development); End-Use (Pharmaceutical and Biopharmaceutical Companies End-Use, CMOs and CROs End-Use, Academic and Research Institutes End-Use)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 41 Featured) -
Avantor, Inc.
CellBios Healthcare & Lifesciences Pvt. Ltd.
Corning, Inc.
Dow, Inc.
Entegris, Inc.
Kiefel GmbH
Meissner Filtration Products, Inc.
PROAnalytics, LLC
Saint-Gobain Life Sciences
Sartorius AG
Single Use Support GmbH
Thermo Fisher Scientific, Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Bioprocess Bags - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rapid Growth in Biopharmaceutical Manufacturing Throws the Spotlight on Bioprocess Bags as Critical Single-Use Components
Rising Demand for Single-Use Solutions in Upstream and Downstream Processes Expands Addressable Market for Bioprocess Bags
Increasing Complexity of Biologics and Cell-Based Therapies Strengthens the Business Case for Customizable Bioprocess Bags
Accelerated Vaccine Development and Pandemic Preparedness Initiatives Propel Demand for Scalable Bag-Based Systems
Growth of Contract Manufacturing Organizations (CMOs) and CDMOs Fuels Market Demand for Ready-to-Deploy, Disposable Bioreactor Bags
Focus on Cross-Contamination Prevention and Batch-to-Batch Consistency Drives Single-Use System Adoption
Technological Advancements in Multi-Layer Films and Barrier Properties Enhance Bag Durability and Compatibility
Expansion of Cell and Gene Therapy Pipelines Creates New Application Opportunities for Bioprocess Bags in Aseptic Processing
Increased Utilization in Media Storage, Buffer Preparation, and Harvesting Processes Sustains Demand Across Bioproduction Stages
Integration of Smart Sensors and Bag Monitoring Technologies Throws the Spotlight on Intelligent Bioprocessing Bags
Eco-Friendly and Recyclable Alternatives Gain Momentum Amid Sustainability Pressures in Biopharma Manufacturing
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Bioprocess Bags Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Bioprocess Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for 2D Bioprocess Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for 2D Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for 3D Bioprocess Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for 3D Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Other Bags & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Other Bags & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Upstream Process by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Upstream Process by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Downstream Process by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Downstream Process by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Process Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Process Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Pharmaceutical & Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 22: USA Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 23: USA 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 24: USA Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 25: USA 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: USA 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
CANADA
TABLE 28: Canada Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 29: Canada 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 30: Canada Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 31: Canada 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
JAPAN
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 34: Japan Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: Japan 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 36: Japan Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 37: Japan 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
CHINA
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 40: China Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: China 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 42: China Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: China 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: China 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
EUROPE
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 46: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 47: Europe 6-Year Perspective for Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 48: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: Europe 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 52: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: Europe 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
FRANCE
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 54: France Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 55: France 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: France 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 58: France Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: France 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
GERMANY
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 60: Germany Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Germany 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 64: Germany Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: Germany 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
ITALY
TABLE 66: Italy Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: Italy 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 70: Italy Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 71: Italy 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
UNITED KINGDOM
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 72: UK Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: UK 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: UK 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 76: UK Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: UK 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
REST OF EUROPE
TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: Rest of Europe 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Rest of Europe 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: Rest of Europe 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
ASIA-PACIFIC
Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: Asia-Pacific 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Asia-Pacific 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Asia-Pacific 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
REST OF WORLD
TABLE 90: Rest of World Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of World 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of World 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
TABLE 94: Rest of World Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 95: Rest of World 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
